Cargando…

Relationship of glycaemic control and hypoglycaemic episodes to 4‐year cardiovascular outcomes in people with type 2 diabetes starting insulin

AIMS: To examine the relationships between glycated haemoglobin (HbA1c) and cardiovascular (CV) events in people beginning insulin in routine clinical practice in Europe, North America and Asia in a non‐interventional study, the Cardiovascular Risk Evaluation in people with Type 2 Diabetes on Insuli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freemantle, N., Danchin, N., Calvi‐Gries, F., Vincent, M., Home, P. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738470/ https://www.ncbi.nlm.nih.gov/pubmed/26511332 http://dx.doi.org/10.1111/dom.12598

Ejemplares similares

Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study
por: Home, Philip, et al.
Publicado: (2018)

A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes
por: Freemantle, N, et al.
Publicado: (2013)

Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes
por: Freemantle, N, et al.
Publicado: (2012)

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study
por: Lane, Wendy, et al.
Publicado: (2021)

Oral Hypoglycaemic Agents: The First Thirty Years
por: Nabarro, John D. N.
Publicado: (1992)

Hypoglycaemic treatment adherence and the association with psychological, self‐management and glycaemic characteristics in adults with type 1 diabetes
por: Martyn‐Nemeth, Pamela, et al.
Publicado: (2019)

Diabetes treatment and hypoglycaemic episodes in elderly patients at nursing homes in Uppsala County
por: Walfridsson, Angelica, et al.
Publicado: (2016)

High number of hypoglycaemic episodes identified by CGM among home-dwelling older people with diabetes: an observational study in Norway
por: Fløde, Mari, et al.
Publicado: (2023)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

New Hypoglycaemic Therapies
por: Gale, Edwin A M
Publicado: (2000)

HYPOGLYCAEMIC PROPERTY OF SHILAJEET AND YASHADA BHASMA
por: Bharati,, et al.
Publicado: (1996)

Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials
por: Freemantle, N, et al.
Publicado: (2013)

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands
por: de Groot, Saskia, et al.
Publicado: (2018)

Pharmacokinetic–pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats
por: Miyazaki, Makoto, et al.
Publicado: (2020)

Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs
por: Alonso-Morán, Edurne, et al.
Publicado: (2015)

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
por: Müller-Wieland, Dirk, et al.
Publicado: (2023)

Studies on the Hypoglycæmic Effect of Tephrosia Purpurea Var. Pumila
por: Swift, H. B. N., et al.
Publicado: (1949)

Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria
por: Weitgasser, Raimund, et al.
Publicado: (2014)

Characteristics of hypoglycaemic episodes in diabetic patients treated at the emergency room of a Portuguese tertiary centre, 2012‐2016
por: Pereira, Catarina A., et al.
Publicado: (2020)

YASADA BHASMA : AN EFFECTIVE HYPOGLYCAEMIC DRUG
por: Prasad, C.M., et al.
Publicado: (1989)

The potential role of GLUT4 transporters and insulin receptors in the hypoglycaemic activity of Ficus lutea acetone leaf extract
por: Olaokun, Oyinlola O, et al.
Publicado: (2014)

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
por: Riddle, M C, et al.
Publicado: (2015)

A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats
por: Osinubi, Abraham A.A., et al.
Publicado: (2018)

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes1
por: Home, P D, et al.
Publicado: (2007)

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
por: Home, Philip D., et al.
Publicado: (2017)

Sustained Liver Glucose Release in Response to Adrenaline Can Improve Hypoglycaemic Episodes in Rats under Food Restriction Subjected to Acute Exercise
por: Babata, Lucas K. R., et al.
Publicado: (2014)

HYPOGLYCAEMIC ACTION OF MOMORDICA CHARANTIA IN NORMAL AND DIABETIC MICE
por: Kavimani, S., et al.
Publicado: (1997)

The Management of Type 2 Diabetic Patients with Hypoglycaemic Agents
por: Tsang, Man-Wo
Publicado: (2012)

Studies on the Hypoglycæmic Effect of Tephrosia Purpurea Var. Pumila
Publicado: (1951)

Possible mechanisms of the hypoglycaemic effect of artesunate: Gender implication
por: Alagbonsi, Abdullateef Isiaka, et al.
Publicado: (2021)

Glycaemic variability is associated with adverse cardiovascular outcomes in patients hospitalised with an acute myocardial infarction
por: Chai, Thora Y., et al.
Publicado: (2019)

Re-contact demographics and clinical characteristics of diabetic patients treated for a hypoglycaemic episode in the pre-hospital environment: a rapid literature review
por: Bloomer, Karl
Publicado: (2019)

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?
por: Home, P. D.
Publicado: (2015)

Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus—a choice determined by metabolic phenotype
por: Sinclair, Alan J., et al.
Publicado: (2022)

Design and Synthesis of Pyrazole-3-one Derivatives as Hypoglycaemic Agents
por: Datar, Prasanna A., et al.
Publicado: (2015)

Hyperinsulinaemic, hypoglycaemic syndrome due to acquired nesidioblastosis in a cat
por: Hambrook, Lydia E, et al.
Publicado: (2016)

The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020)

Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2023)

14-Year Risk of All-Cause Mortality According to Hypoglycaemic Drug Exposure in a General Population
por: Bérard, Emilie, et al.
Publicado: (2014)

Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes
por: Home, Philip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_98sek6gpk851i9f7g6gof8r3on